Loss of TAX1BP1-Directed Autophagy Results in Protein Aggregate Accumulation in the Brain

Shireen A Sarraf1, Hetal V Shah2, Gil Kanfer1

  • 1Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Molecular Cell
|November 18, 2020
PubMed

Insights

The autophagy receptor TAX1BP1 is crucial for clearing toxic protein aggregates in neurons, protecting against neurodegenerative disease. Its absence leads to aggregate buildup and neuronal damage.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Molecular Biology

Background:

  • Protein aggregates disrupt cellular homeostasis and are linked to neurodegenerative diseases.
  • Selective autophagic elimination of aggregates is vital for protein quality control, but the targeting mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of autophagy receptor proteins, specifically TAX1BP1, in the clearance of proteotoxic aggregates.
  • To determine the therapeutic potential of TAX1BP1 in neurodegenerative diseases.

Main Methods:

  • Comparison of autophagy receptor requirements (OPTN, NBR1, p62, NDP52, TAX1BP1) for aggregate clearance.
  • Assessment of TAX1BP1's role in aggregate clearance in human induced pluripotent stem cell-derived neurons and TAX1BP1 knockout mouse models.
  • Analysis of protein aggregate levels, ubiquitin conjugates, and lipofuscin accumulation.

Main Results:

  • Endogenous TAX1BP1 is recruited to and essential for clearing stress-induced protein aggregates.
  • Ectopic TAX1BP1 expression enhances aggregate clearance via autophagy, improving neuronal viability.
  • TAX1BP1 depletion increases sensitivity to proteotoxicity, and its loss in vivo causes ubiquitin conjugate and lipofuscin accumulation in mouse brains.

Conclusions:

  • TAX1BP1 plays a critical role in the selective autophagic clearance of proteotoxic aggregates.
  • TAX1BP1 exhibits specific expression in the brain and mediates the clearance of diverse cytotoxic proteins.
  • TAX1BP1 represents a potential therapeutic target for neurodegenerative diseases characterized by protein aggregate accumulation.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.3K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.6K